Vir Biotechnology Shares Jump 11% to $12.21 on Friday
Vir Biotechnology shares rose 11% to $12.21 on Friday, following positive hepatitis delta trial results.
Shares of Vir Biotechnology (VIR) surged over nearly 15% overnight heading into Monday after positive hepatitis delta trial results sparked retail buyout speculation and bets on bigger long-term gains.VIR stock jumped 11% to $12.21 on Friday, bringing its year-to-date gain to about 102%, well above…